Article Information
History
- October 14, 2020.
Article Versions
- Version 1 (July 8, 2020 - 08:06).
- Version 2 (October 13, 2020 - 12:36).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mikail Dogan1,
- Lina Kozhaya1,
- Lindsey Placek1,
- Courtney L. Gunter1,
- Mesut Yigit1,
- Rachel Hardy1,
- Matt Plassmeyer3,
- Paige Coatney3,
- Kimberleigh Lillard3,
- Zaheer Bukhari4,
- Michael Kleinberg5,
- Chelsea Hayes6,
- Moshe Arditi7,
- Ellen Klapper6,
- Noah Merin8,
- Bruce T Liang5,
- Raavi Gupta4,
- Oral Alpan3 and
- Derya Unutmaz1,2,*
- 1Jackson Laboratory for Genomic Medicine, Farmington, Connecticut
- 2Department of Immunology, University of Connecticut School of Medicine, Farmington, CT
- 3Amerimmune, Fairfield, VA
- 4SUNY Downstate Medical Center, Department of Pathology, Brooklyn, NY
- 5Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT
- 6Department of Pathology & Laboratory Medicine and Transfusion Medicine Cedars-Sinai Medical Center, Los Angeles, CA
- 7Department of Pediatric, Division of Pediatric Infectious Diseases and Immunology, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048
- 8Department of Internal Medicine, Division of Hematology Cedars-Sinai Medical Center, Los Angeles, CA
- ↵* Corresponding author E-mail: derya{at}mac.com
Posted October 14, 2020.
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19
